Edward J Dulac Iii Intellia Therapeutics, Inc. (NTLA) insider trading activity
Edward J Dulac Iii is EVP, Chief Financial Officer of Intellia Therapeutics, Inc.. Currently has a direct ownership of 106,062 shares of NTLA, which is worth approximately $1.14 Million. The most recent transaction as insider was on Jul 23, 2025, when has been sold 7,462 shares (Common Stock) at a price of $14.02 per share, resulting in proceeds of $104,617. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
106K
6.57%
3M change
59.91%
12M change
Total Value Held
$1.14 Million
Edward J Dulac III Transaction History
Also insider at
EJD
Edward J Dulac Iii
EVP, Chief Financial Officer
San Diego, CA